Global Chimeric Antibody 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI01256931

Publication Date:

January 16, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Chimeric Antibody market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Chimeric antibody is the first genetically engineered antibody to be produced successfully. It is made by splicing the V region gene of mouse antibody and the C region gene of human antibody into chimeric gene, and then inserting the vector, transfecting the antibody molecule expressed in myeloma tissue. Because it reduces the murine component, it reduces the adverse reactions caused by murine antibody and helps to improve the curative effect.
United States market for Chimeric Antibody is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Chimeric Antibody is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Chimeric Antibody is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Chimeric Antibody players cover Creative-Biolabs, Biotem, OmniAb Technology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淐himeric Antibody Industry Forecast鈥� looks at past sales and reviews total world Chimeric Antibody sales in 2024, providing a comprehensive analysis by region and market sector of projected Chimeric Antibody sales for 2025 through 2031. With Chimeric Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chimeric Antibody industry.
This Insight Report provides a comprehensive analysis of the global Chimeric Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Chimeric Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Chimeric Antibody market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chimeric Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chimeric Antibody.
This report presents a comprehensive overview, market shares, and growth opportunities of Chimeric Antibody market by product type, application, key players and key regions and countries.
Segmentation by Type:
IgG
IgM
IgA
Others
Segmentation by Application:
Hospital
Scientific Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Creative-Biolabs
Biotem
OmniAb Technology

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Chimeric Antibody 麻豆原创 Size (2020-2031)
2.1.2 Chimeric Antibody 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Chimeric Antibody by Country/Region (2020, 2024 & 2031)
2.2 Chimeric Antibody Segment by Type
2.2.1 IgG
2.2.2 IgM
2.2.3 IgA
2.2.4 Others
2.3 Chimeric Antibody 麻豆原创 Size by Type
2.3.1 Chimeric Antibody 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Chimeric Antibody 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Chimeric Antibody Segment by Application
2.4.1 Hospital
2.4.2 Scientific Research
2.4.3 Others
2.5 Chimeric Antibody 麻豆原创 Size by Application
2.5.1 Chimeric Antibody 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Chimeric Antibody 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Chimeric Antibody 麻豆原创 Size by Player
3.1 Chimeric Antibody 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Chimeric Antibody Revenue by Player (2020-2025)
3.1.2 Global Chimeric Antibody Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Chimeric Antibody Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Chimeric Antibody by Region
4.1 Chimeric Antibody 麻豆原创 Size by Region (2020-2025)
4.2 Global Chimeric Antibody Annual Revenue by Country/Region (2020-2025)
4.3 Americas Chimeric Antibody 麻豆原创 Size Growth (2020-2025)
4.4 APAC Chimeric Antibody 麻豆原创 Size Growth (2020-2025)
4.5 Europe Chimeric Antibody 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Chimeric Antibody 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Chimeric Antibody 麻豆原创 Size by Country (2020-2025)
5.2 Americas Chimeric Antibody 麻豆原创 Size by Type (2020-2025)
5.3 Americas Chimeric Antibody 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chimeric Antibody 麻豆原创 Size by Region (2020-2025)
6.2 APAC Chimeric Antibody 麻豆原创 Size by Type (2020-2025)
6.3 APAC Chimeric Antibody 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Chimeric Antibody 麻豆原创 Size by Country (2020-2025)
7.2 Europe Chimeric Antibody 麻豆原创 Size by Type (2020-2025)
7.3 Europe Chimeric Antibody 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Chimeric Antibody by Region (2020-2025)
8.2 Middle East & Africa Chimeric Antibody 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Chimeric Antibody 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Chimeric Antibody 麻豆原创 Forecast
10.1 Global Chimeric Antibody Forecast by Region (2026-2031)
10.1.1 Global Chimeric Antibody Forecast by Region (2026-2031)
10.1.2 Americas Chimeric Antibody Forecast
10.1.3 APAC Chimeric Antibody Forecast
10.1.4 Europe Chimeric Antibody Forecast
10.1.5 Middle East & Africa Chimeric Antibody Forecast
10.2 Americas Chimeric Antibody Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Chimeric Antibody Forecast
10.2.2 Canada 麻豆原创 Chimeric Antibody Forecast
10.2.3 Mexico 麻豆原创 Chimeric Antibody Forecast
10.2.4 Brazil 麻豆原创 Chimeric Antibody Forecast
10.3 APAC Chimeric Antibody Forecast by Region (2026-2031)
10.3.1 China Chimeric Antibody 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Chimeric Antibody Forecast
10.3.3 Korea 麻豆原创 Chimeric Antibody Forecast
10.3.4 Southeast Asia 麻豆原创 Chimeric Antibody Forecast
10.3.5 India 麻豆原创 Chimeric Antibody Forecast
10.3.6 Australia 麻豆原创 Chimeric Antibody Forecast
10.4 Europe Chimeric Antibody Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Chimeric Antibody Forecast
10.4.2 France 麻豆原创 Chimeric Antibody Forecast
10.4.3 UK 麻豆原创 Chimeric Antibody Forecast
10.4.4 Italy 麻豆原创 Chimeric Antibody Forecast
10.4.5 Russia 麻豆原创 Chimeric Antibody Forecast
10.5 Middle East & Africa Chimeric Antibody Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Chimeric Antibody Forecast
10.5.2 South Africa 麻豆原创 Chimeric Antibody Forecast
10.5.3 Israel 麻豆原创 Chimeric Antibody Forecast
10.5.4 Turkey 麻豆原创 Chimeric Antibody Forecast
10.6 Global Chimeric Antibody Forecast by Type (2026-2031)
10.7 Global Chimeric Antibody Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Chimeric Antibody Forecast
11 Key Players Analysis
11.1 Creative-Biolabs
11.1.1 Creative-Biolabs Company Information
11.1.2 Creative-Biolabs Chimeric Antibody Product Offered
11.1.3 Creative-Biolabs Chimeric Antibody Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Creative-Biolabs Main Business Overview
11.1.5 Creative-Biolabs Latest Developments
11.2 Biotem
11.2.1 Biotem Company Information
11.2.2 Biotem Chimeric Antibody Product Offered
11.2.3 Biotem Chimeric Antibody Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Biotem Main Business Overview
11.2.5 Biotem Latest Developments
11.3 OmniAb Technology
11.3.1 OmniAb Technology Company Information
11.3.2 OmniAb Technology Chimeric Antibody Product Offered
11.3.3 OmniAb Technology Chimeric Antibody Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 OmniAb Technology Main Business Overview
11.3.5 OmniAb Technology Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.